State of Alaska Department of Revenue Trims Position in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

State of Alaska Department of Revenue trimmed its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 3.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,328 shares of the business services provider’s stock after selling 635 shares during the period. State of Alaska Department of Revenue’s holdings in Cross Country Healthcare were worth $460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. Blair William & Co. IL purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at approximately $2,550,000. Jacobs Levy Equity Management Inc. increased its stake in shares of Cross Country Healthcare by 63.7% during the third quarter. Jacobs Levy Equity Management Inc. now owns 370,224 shares of the business services provider’s stock valued at $9,178,000 after buying an additional 144,035 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Cross Country Healthcare by 80.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 401,887 shares of the business services provider’s stock valued at $9,963,000 after acquiring an additional 179,093 shares in the last quarter. Paradiem LLC lifted its stake in Cross Country Healthcare by 5.0% in the third quarter. Paradiem LLC now owns 131,989 shares of the business services provider’s stock worth $3,272,000 after acquiring an additional 6,341 shares during the period. Finally, Qube Research & Technologies Ltd grew its holdings in Cross Country Healthcare by 946.0% during the 3rd quarter. Qube Research & Technologies Ltd now owns 115,318 shares of the business services provider’s stock worth $2,859,000 after acquiring an additional 104,293 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $16.95, for a total value of $105,361.20. Following the completion of the transaction, the insider now owns 35,101 shares of the company’s stock, valued at $594,961.95. The transaction was disclosed in a filing with the SEC, which is available at this link. 5.50% of the stock is owned by insiders.

Cross Country Healthcare Price Performance

Cross Country Healthcare stock opened at $17.56 on Friday. Cross Country Healthcare, Inc. has a 1-year low of $15.65 and a 1-year high of $28.75. The business has a fifty day moving average price of $18.45 and a 200-day moving average price of $20.76. The stock has a market capitalization of $608.98 million, a price-to-earnings ratio of 8.65, a PEG ratio of 1.87 and a beta of 0.75.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings results on Wednesday, February 21st. The business services provider reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.02. Cross Country Healthcare had a return on equity of 16.93% and a net margin of 3.60%. The business had revenue of $414.04 million during the quarter, compared to the consensus estimate of $404.42 million. During the same quarter last year, the company earned $1.09 earnings per share. The company’s quarterly revenue was down 34.1% on a year-over-year basis. On average, equities research analysts anticipate that Cross Country Healthcare, Inc. will post 0.94 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Truist Financial lowered their price target on shares of Cross Country Healthcare from $22.00 to $16.00 and set a “hold” rating for the company in a research report on Thursday, February 22nd. Benchmark reduced their price objective on shares of Cross Country Healthcare from $24.00 to $21.00 and set a “buy” rating for the company in a research note on Thursday, February 22nd. TheStreet cut Cross Country Healthcare from a “b-” rating to a “c+” rating in a research report on Friday, March 1st. Finally, Barrington Research reduced their price target on Cross Country Healthcare from $26.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 27th. Six analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $21.67.

Cross Country Healthcare Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.